ArticleCureus2026
Elevated Cancer Antigen 125 (CA125) Levels in an Indian Male: A Diagnostic and Therapeutic Marker in Extrapulmonary Tuberculosis.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A patient with ascites and evening chills presenting to OPD was suspected of having tuberculosis (TB) peritonitis after ruling out possible diagnoses. Abdominal paracentesis for molecular studies, including PCR and CBNAAT (cartridge-based nucleic acid amplification test), was negative. Based on previous evidence and investigation findings from our case, we report the value and application of cancer antigen 125 (CA125) in the diagnosis and follow-up of this case of extrapulmonary TB. This case highlights the potential role of CA125 as a supportive diagnostic and prognostic marker in extrapulmonary TB. The non-invasive and cost-effective nature of CA125 may aid in monitoring anti-tubercular therapy response, an alternative to invasive investigation techniques.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.